Stock RSPI RESPIRERX PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Delayed OTC Markets
Other stock markets
 09:36:18 2024-05-22 am EDT 		5-day change 1st Jan Change
0.000825 USD +3.12% Intraday chart for RespireRx Pharmaceuticals Inc. -11.11% -11.11%
Apr. 10 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
Mar. 20 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. News RespireRx Pharmaceuticals Inc.
  5. MarketScreener Editorial Features
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW